Pyxis Oncology, Inc. (PYXS)
4.22
-0.10
(-2.31%)
USD |
NASDAQ |
Dec 05, 16:00
4.23
+0.01
(+0.24%)
After-Hours: 20:00
Pyxis Oncology EPS Diluted (Quarterly): -0.3517 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| Pfizer Inc. | 0.6197 |
| Ironwood Pharmaceuticals, Inc. | 0.2294 |
| Akebia Therapeutics, Inc. | 0.002 |
| PTC Therapeutics, Inc. | 0.195 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.00M |
| Total Expenses (Quarterly) | 22.00M |
| Enterprise Value | 204.10M |
| Earnings Yield | -37.72% |
| Normalized Earnings Yield | -31.88 |